Comparing Blood Sugar Levels and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplements
Completed · Not applicable · Has a placebo group
Conditions studied: Blood Sugar, Endothelial Function
In brief
To purpose of this study is to assess the effectiveness, safety and tolerability of PEAK ATP® with GlycoCarn®, PEAK ATP® and GlycoCarn® on levels of blood sugar and endothelial function improvement which may lead to improved vascular health.
Key facts
- Study ID
- NCT01855373
- Run by
- Supplement Formulators, Inc.
- People needed
- 60
- Starts
- 2012-07-01
- Expected to finish
- 2016-04-01
- Last updated by the study team
- 2016-04-15
Who can join
Age: 25 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- Life Extension Clinical Research Inc. — Fort Lauderdale, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.